Member Info for PDMSPiper

I always said that the Mologic Elisa Test was our most valuable under the radar product and would take people by surprise in the amount of revenue it generates for ODX.

It would take a special kind of stupid to take any profit here now with everything we’ve waited for coming to fruition and condensed into the next few weeks.
March and April are set to be absolutely thrilling for Omega shareholders. This is the second big RNS and the first big contract RNS on the way to an Mcap up where AVCT and NCYT already are. Should be well up towards £3 per share in April and that’s still only where AVCT are and they have no contracts and no tests!

£3 is now very, very likely. Those with patience and courage who set higher targets here will undoubtedly reap the best rewards.

GLA

Expecting the level of buying seen before yesterdays close to continue and for ODX to print a new 52 week high this week, over 113.5p, before news on several long term Gov DHSC testing supply contracts next week. GLA.

Lol Avacta have had affirmers for years and years and never managed to come up with one anti viral application. Nothing on sars cov-1, nothing on hiv, nothing on mers, nothing.
The ODX antigen Test is the Mologic developed lfd.
Any manufacturer like ODX will always agree to manufacture tests for a development company like AVCT if and when they ever develop a successful test. That doesn’t mean you ever got one. Lol.

Like I say keep smoking the hopium in the cult of Avacta. Nothing changes. Have fun losing your money. Lol.

Once more for the hard of thinking slow learners. The award will be 2M a day, 60Million a month, 720 Million rapid antigen lad tests a year split between these three companies.
This is why Mologic have opened a brand new factory and ODX have expanded massively at Alva.

The base tech is the Mologic antigen LFD. The qty is 2 million a day and it is absolutely nothing to do with Avacta or affirmers.

Keep smoking the hopium by all means but Avacta has absolutely no involvement here. Nothing. Thanks.

The portion of the article that says the 3 companies including Omega have been awarded 2M tests a week is a mistake by the journalist, a typo because she is unfamiliar with the huge scale at which these tests are manufactured.
The actual figure ODX and co have been awarded is 2 Million tests per DAY!
This becomes obvious when you read further and the article references the history behind this....

“PA Consulting to find suitable British manufacturers of LFD (lateral flow device) tests, with the aim of scaling up to producing 2m tests a day by April”

I’m sure it will all become clear in the ODX Gov Contract award RNS which shouldn’t be far away now.
The award will be for the ODX/Mologic saliva Antigen rapid lateral flow test at a production rate of 2 Million tests per DAY. DAY! DAY! DAY!

Thanks. GLA.

No, Company will RNS when contracts are signed. This is leaked inside info that FT have got from a reliable source at this stage.
Company will RNS when all finalized but this is as good as it gets for punters. An opportunity to buy in before nailed on company transformational news. Opportunities like this don’t pop up every day. After all, we are usually the last to know everything aren’t we.

Congratulations to the patient who have learned from their past mistakes, trusted in their research on the fundamentals and held through the FUD.
I still hold over 100,000 ODX shares but went off to concentrate on my crypto PF which has gone well. I’ll be scrabbling with everybody else to buy more on Monday and will buy every dip until this contract news lands.
Well done all holders. Enjoy the success and don’t let them go too early after all you’ve gone through to get here. Make the reward count.

GLA. Piper.

My £8k full or kill got dealt at 24.3618. It was totally impossible to buy the bottom. They were taking stock to offload higher. Happy with that buy though.

I’m happy to take the bet on another rise toward 30 from here over the next 2-3 months.

I doubt many are bailing as it’s impossible to get a live quote to buy on HL. I’m trying to buy £8k. Went right down to £1k buys and still NT on HL. I’ve put in a fill or kill at 24.5 but it’s not been filled yet but still pending.

The Khamanis gave themselves a £150million fat cat bonus without any consultation with shareholders. Bunch of market trader scammers made good. Zero Class or integrity.....

https://www.ft.com/content/97d53c4d-01bf-4ade-8e38-8518402a9c38

“A man is known by the company he keeps” Aesop.

iPhone trade what is this UKRCT?

UKRCT version of the antigen test?

What are you talking about. Omegas MTA with Mologic to manufacture the Antigen LFT they are developing is totally separate from out involvement with the RTC. There is no RTC Antigen Test.

Don’t accuse the board of being stupid then three posts later put out a post that is just totally idiotic and incorrect. Not half as smart as you think you are obviously.

The agreement with Mologic is not a licensing agreement. It is a “Material Transfer Agreement.

You will notice that Omega are trademarking the Mologic tests and manufacturing them under the “Visitect” brand.

Mologic are not interested in profit. Mologic are a non profit charitable organization funded by the Gates foundation. Their goal is to get tests to market and get them out to the Population.

It isn’t your average commercial licensing agreement FFS DYOR before making incorrect uninformed statements. Thanks.

“Manufacturing is typically low margin”.

This comment exposes the lack of research DD77 has done and his lack of knowledge.

Margin in the Biotech sector is typically 60-70%.

The trademarked Visitect CD4 HIV test sells into Africa at 60% margin.

Do a bit of basic research before gobbing off pretending to be an expert. Thanks.

I’ve been in ODX since March.

Punit has been on this board trying to spread discontentment since about April, when we were at about 25p.

Since 25p Punit has been scheptical about potential. Share price now: 93p.

Make of that what you will.

Don’t be so paranoid and defensive Afamaman. It isn’t baiting.

I said nothing negative about Avacta. I didn’t say the Avacta Mcap is not justified. I didn’t say anything about Avacta at all except for what their Mcap factually is. How is that baiting you soft Turnip.

ODX can reach Avacta Mcap as we have so much potential. That’s the message.

Wind your neck in Princess.

3 bagger coming.

AVCT Mcap is 450million.

ODX Mcap is 150 million.

ODX have a suite of 5 covid tests and other testing products already on the market and gov MHRA rollout of the ABC-19 test imminent now after BBI let that genie out the bottle.

Omega need to 3 bag from here just to equal Avactas Mcap and that’s very possible, more than likely.

An ODX 3 bagger from here is around £2.50.

Testing all over BBC news now. Starmer infected, so he says lol.